Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
12/2003
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003106380A2 Fluorobenzamides
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667414 Renin inhibitors; hypertensive agents
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/18/2003WO2003104217A2 Prodrugs of excitatory amino acids
12/18/2003WO2003103722A1 New agents for magnetic imaging method
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003US20030232932 Conformationally constrained compounds as dendrimer cores
12/18/2003US20030232889 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
12/18/2003US20030232883 N-acylamino benzyl ether derivatives
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6663898 Carbon-substituted diketopiperazine delivery systems
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/16/2003CA2195125C Difluorostatone antiviral agents
12/16/2003CA2146708C Process for producing glutamine derivative
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003101935A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments
12/11/2003US20030229050 Insecticidal anthranilamides
12/10/2003EP1369134A1 New agents for magnetic imaging method
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP0983230B1 Yellow polymorph of 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihydroxypropyl)-isophthalamide
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/04/2003WO2003099832A1 Hydroxy diphosphines and their use in catalysis
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099338A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/04/2003WO2003099202A2 Beta-secretase inhibitors
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2002088069A9 Compounds useful as intermediates for 4-aminoquinoline derivatives
12/04/2003US20030225272 Novel mmp-2/mmp-9 inhibitors
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003US20030225076 Mitogen ERK Kinase ("MEK") enzyme inhibitors
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003CN1129566C Process for crystallisation of sterically hindered compound
12/02/2003US6656498 Cationic liposomes for gene transfer
12/02/2003CA2248317C Anticonvulsant enantiomeric amino acid derivatives
11/2003
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097579A1 Production process of aminomethyl group-containing benzamide compound
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003005971A3 Tetracycline compounds having target therapeutic activities
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220404 Process for the preparation of combretastatins
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220196 Phenyl-substituted-2enamino-keto nitriles
11/26/2003EP1364941A1 Gelling agents
11/26/2003EP1021099B1 Anti-bacterial amine derivatives
11/26/2003CN1458143A Process for preparing N-aroyl-L-glutaminic acid
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6653087 Convergent synthesis of combinatorial library
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003US6652834 Tensioactive properties, long lasting activity in the blood pool
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216589 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability
11/20/2003US20030216576 Methods for preparing CETP inhibitors
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216466 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 162